Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported associated with Zenon treatment. Stop using Zenon and seek medical attention immediately if you notice any of the symptoms described in section 4.
Other medications and Zenon
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. In particular, inform your doctor if you are taking a medication(s) with any of the following active ingredients:
You must inform the doctors who will prescribe a new medication that you are taking Zenon.
Taking Zenon with alcohol
If you regularly consume large amounts of alcohol, do not take Zenon 40mg/10 mg tablets (the highest dose).
Pregnancy and breastfeeding
Do not take Zenon if you are pregnant, trying to become pregnant, or think you may be pregnant.If you become pregnant while taking Zenon, stop taking it immediately and inform your doctor.
Do not take Zenon if you are breastfeeding, as it is unknown whether the medication passes into breast milk.
Children and adolescents
Zenon is not recommended for use in children and adolescents under 18 years of age.
Driving and operating machinery
Zenon is not expected to interfere with your ability to drive or operate machinery. However, some people may feel dizzy after taking Zenon. If you feel dizzy, do not drive or operate machinery.
Zenon contains lactose (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1mmol) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one tablet once a day.
Zenon is not suitable for starting treatment.
If your cholesterol level is not controlled, your doctor will determine the appropriate tablet dose for you, depending on your current treatment and your personal risk situation.
The initiation of treatment or dose adjustments, if necessary, should only be made by taking the active ingredients separately, and once the appropriate doses are adjusted, it is possible to switch to the appropriate dose of Zenon.
The maximum daily dose of rosuvastatin is 40 mg. This dose is only for patients with high cholesterol levels and a high risk of suffering a heart attack or stroke, whose cholesterol levels do not decrease enough with 20 mg.
Try to take your tablet at the same time every day, it will help you remember. You can take it with or without food. Swallow each tablet whole with water.
If your doctor has prescribed Zenon together with another cholesterol-lowering medication that contains the active ingredient cholestyramine or another medication that contains a bile acid sequestrant, you must take Zenon at least 2 hours before or 4 hours after taking the bile acid sequestrant.
Regular cholesterol level checks
It is essential that you attend your doctor regularly for cholesterol checks, in order to verify that your cholesterol levels have normalized and are maintained at appropriate levels.
Your doctor may decide to increase your dose so that you are taking the appropriate amount of medication for you.
If you takemore Zenon than you should
Contact your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount ingested.
If you forgot to take Zenon
Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Zenon
Consult your doctor or pharmacist because your cholesterol levels may increase again.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking Zenon and seek medical help immediately if you experience any of the following side effects:
Other side effects
Common(may affect up to 1 in 10 people):
Diarrhea; flatulence; feeling tired; high levels in some blood test results for liver function (transaminases); headache; stomach pain; constipation; nausea; muscle pain; weakness; dizziness;increased protein in urine, which usually returns to normal on its own without the need to stop Zenon treatment (only for rosuvastatin 40 mg); diabetes - this is more likely if you have high blood sugar and lipid levels, being overweight, and high blood pressure. Your doctor will monitor you while taking this medicine.
Uncommon(may affect up to 1 in 100 people):
High levels in some blood test results for muscle function (creatine kinase test); cough; indigestion; heartburn; joint pain; muscle spasms; neck pain; loss of appetite; hot flashes; high blood pressure; numbness; dry mouth; stomach inflammation; tingling; rash; urticaria, and other skin reactions; back pain; muscle weakness; arm and leg pain; swelling, especially in hands and feet;increased protein in urine, which usually returns to normal on its own without the need to stop Zenon treatment (only for rosuvastatin 10 mg and 20 mg).
Rare(may affect up to 1 in 1,000 people):
Reduction in the number of blood cells that can cause bruising / bleeding (thrombocytopenia);intense stomach pain (pancreatitis).
Very rare(may affect 1 in 10,000 people):
Jaundice (yellow skin and eyes); hepatitis (inflamed liver); blood in urine; nerve damage in legs and arms (numbness); memory loss; gynecomastia (enlarged breasts in men).
Frequency not known(cannot be estimated from available data):
Difficulty breathing; swelling;sleep disturbances, including insomnia and nightmares; sexual dysfunction; depression; respiratory problems, including persistent cough and/or difficulty breathing or fever; tendon injuries; constant muscle weakness; red, elevated rash, sometimes with target-shaped lesions (erythema multiforme); muscle sensitivity; gallstones or inflammation of the gallbladder (which may cause abdominal pain, nausea, vomiting).
Myasthenia gravis (a disease that causes generalized muscle weakness, which in some cases affects the muscles used for breathing).
Myasthenia ocular (a disease that causes weakness of the eye muscles).
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and blister pack after CAD. The expiration date is the last day of the month indicated.
Store below 30 °C. Store in the original packaging to protect it from light and moisture.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE drop-off point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Zenon
Zenon 20 mg/10 mg also contains yellow iron oxide (E172).
Appearance of the product and contents of the package
Zenon 10 mg/10 mg are film-coated tablets (tablets), white to off-white in color, round, biconvex, with a diameter of approximately 9.1 mm.
Zenon 20 mg/10 mg are film-coated tablets (tablets), yellow to light yellow in color, round, biconvex, with a diameter of approximately 9.9 mm.
The film-coated tablets are packaged in blisters and in a folding carton.
Available packaging sizes: 10, 15, 30, 60, 90, 100 film-coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
sanofi-aventis, S.A.
C/ Rosselló i Porcel, 21
08016 Barcelona
Spain
Responsible manufacturer
Zentiva k.s
U kabelovny 130
102 37-Prague (Czech Republic)
or
Sanofi Winthrop Industrie
30-36 avenue Gustave Eiffel
37100 Tours, France
or
Sanofi-Aventis Deutschland GmbH,
Industriepark Hoechst-
Brueningstrasse 50
65926 Frankfurt am Main, Germany
This medicinal product is authorized in the Member States of the European Economic Area with the following names:Rosuvastatin/Ezetimib Sanofi in the Czech Republic, SUVREZA in France, Zenon in Germany and Spain.
Last revision date of this leaflet:September 2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.